Recently, the A-share market continued to adjust. The Shanghai and Shenzhen 300, Science and Technology Innovation and GEM broad-based indices showed significant retracement, and most industry sectors weakened simultaneously. However, there are still sectors in the shaken market that have broken out of the structural market. The Securities Times reporter combed through and found that in January, dozens of funds still bucked the trend and achieved returns of more than 20%, and the main profit line was clearly divided. The pharmaceutical sector, which had been dormant for a long time, made a strong breakthrough with innovative drugs and industry sentiment restoration. Crude oil funds also ushered in a sharp rise at the same time due to geographical conflicts.

Recently, the A-share market continued to adjust. The Shanghai and Shenzhen 300, Science and Technology Innovation and GEM broad-based indices showed significant retracement, and most industry sectors weakened simultaneously. However, there are still sectors in the shaken market that have broken out of the structural market. The Securities Times reporter combed through and found that in January, dozens of funds still bucked the trend and achieved returns of more than 20%, and the main profit line was clearly divided. The pharmaceutical sector, which had been dormant for a long time, made a strong breakthrough with innovative drugs and industry sentiment restoration. Crude oil funds also ushered in a sharp rise at the same time due to geographical conflicts.